Downregulation of ANXA10 associated with malignant phenotype of liver cells, and correlated with vascular invasion, early recurrence and poor prognosis of HCC patients, suggesting that ANXA10 might be a potential tumor suppressor gene [114]. This evidence concerns the gene ANXA10 and hepatocellular carcinoma.